ABBV vs EVER · P/E 81, rev $61.16B vs P/E 6.6, rev $500.2M
AbbVie Inc (ABBV) versus EverQuote Inc Class A (EVER) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
EverQuote Inc Class A (EVER) is a internet content & information company listed on US.
Latest reported ABBV revenue for 2025-12-31 was $61.16B. Net income was $4.23B. Revenue was up 305.0% from 2024-12-31 to 2025-12-31. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported EVER revenue for 2024-12-31 was $500.2M. Net income was $32.2M. Revenue was up 73.7% from 2023-12-31 to 2024-12-31. EVER currently screens at market cap $683.4M and trailing P/E 6.6.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. EVER currently screens at market cap $683.4M and trailing P/E 6.6.
Not investment advice. Open the ABBV and EVER stock pages for the full models.
Not investment advice.